Table 2.
Relationships between ultrasonography (USG) and patient and disease characteristics
| Factor | USG | P | |||
|---|---|---|---|---|---|
| Normal (n = 35) | Pathologic (n = 34) | ||||
| N | % | N | % | ||
| Age (months) | 11.8 ± 5.6 (Median = 11) |
12.08 ± 5.9 (Median = 11.5) |
0.780 | ||
| Sex (Male/Female) | 22/13 | 21/13 | 0.56 | ||
| Use of mother's milk (months) | 9.1 ± 5.1 (Median = 11) |
7.3 ± 3.8 (Median = 6.5) |
0.15 | ||
| Smoking in the house | 16 | 45.7 | 18 | 52.8 | 0.36 |
| Use of vitamin D | 35 | 100.0 | 31 | 91.2 | 0.11 |
| Risk factor | 4 | 11.4 | 17 | 50 | 0.01 |
| Duration of symptoms (days) | 4.5 ± 2.8 (Median = 4) |
4.2 ± 3.4 (Median = 3) |
0.41 | ||
| Fever | 13 | 37.1 | 18 | 52.9 | 0.23 |
| Cough | 35 | 100.0 | 31 | 91.2 | 0.11 |
| Rhinitis | 31 | 88.6 | 24 | 70.6 | 0.078 |
| Wheezing | 35 | 100 | 33 | 97.1 | 0.493 |
| Rale | 29 | 82.9 | 30 | 88.2 | 0.734 |
| Rhonchus | 34 | 97.1 | 33 | 97.1 | 1.000 |
| Use of accessory respiratory muscles | 13 | 37.1 | 14 | 41.2 | 0.808 |
| Tachypnea | 16 | 45.7 | 14 | 41.2 | 0.809 |
| Nasal flaring | 11 | 31.4 | 11 | 32.4 | 1.000 |
| Antibiotic treatment (n) | 22 | 62.9 | 22 | 64.7 | 1.000 |
| Recovery period (days) | 4.6 ± 2.1 (Median = 4) |
5.3 ± 2.7 (Median = 5) |
0.20 | ||